| Johns Hopkins Hospital, The | |
| 600 North Wolfe Street, Baltimore, Maryland 21287 | |
| (410) 955-9540 | |
| Name | Johns Hopkins Hospital, The |
|---|---|
| Type | Acute Care Hospital |
| Location | 600 North Wolfe Street, Baltimore, Maryland |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 210009 |
| NPI Number | 1013053941 |
| Organization Name | JOHNS HOPKINS UNIVERSITY, PM&R DEPT |
| Address | 600 N Wolfe St # 160, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-502-2447 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1013072917 |
| Organization Name | JOHNS HOPKINS UNIVERSITY, PM&R DEPT |
| Address | 600 N Wolfe Street Phipps Bldg 160, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-502-2447 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1013143213 |
| Organization Name | JOHNS HOPKINS INSTITUTIONS |
| Address | 600 N Wolfe St, Baltimore, MD 21287 |
| Hospital Type | Special Hospital |
| Phone Number | 410-614-6673 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1013199983 |
| Organization Name | JOHNS HOPKINS UNIVERSITY |
| Address | 600 N Wolfe St, Cmsc 309, Baltimore, MD 21287 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 410-955-7858 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1104234590 |
| Organization Name | THE JOHNS HOPKINS HOSPITAL |
| Address | 1800 Orleans St, Bloomberg 9306, Baltimore, MD 21287 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 410-955-5177 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1154764991 |
| Organization Name | THE JOHNS HOPKINS HOSPITAL |
| Address | 600 N Wolfe St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 651-983-3379 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1215073309 |
| Organization Name | JOHNS HOPKINS UNIVERSITY, PM&R DEPARTMENT |
| Address | 600 N Wolfe St # 160, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-502-2447 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1215106653 |
| Organization Name | JOHNS HOPKINS MEDICAL INSTITUTIONS |
| Address | 600 N Wolfe St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 443-997-8688 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1285748400 |
| Organization Name | JOHNS HOPKINS HOSPITAL PHARMACY |
| Address | 600 N Wolfe St, Carnegie 180, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 410-955-6874 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1346591823 |
| Organization Name | JOHNS HOPKINS UNIVERSTIY |
| Address | 600 N Wolfe St, Department Of Pediatric Surgery, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 443-963-8474 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1447619044 |
| Organization Name | JOHNS HOPKINS HOSPITAL |
| Address | 600 N Wolfe St, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-614-3234 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1578597993 |
| Organization Name | THE JOHNS HOPKINS HOSPITAL |
| Address | 600 N Wolfe St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 855-662-3017 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1598072787 |
| Organization Name | JOHNS HOPKINS UNIVERSITY |
| Address | 600 N. Wolfe Street, Meyer 218, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 410-502-6338 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1730502345 |
| Organization Name | JOHNS HOPKINS HOSPITAL |
| Address | 401 N Broadway St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 410-955-8998 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1780134734 |
| Organization Name | JOHNS HOPKINS CHILDREN'S CENTER |
| Address | 1800 Orleans St, Suite 7311, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 443-287-3486 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1801932710 |
| Organization Name | JOHNS HOPKINS UNIVERSITY, PM AND R |
| Address | 600 N Wolfe St # 160, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-502-2447 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1831252022 |
| Organization Name | JOHNS HOPKINS UNIVERSITY |
| Address | 600 N Wolfe St, Phipps 160, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 410-502-2247 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1841537255 |
| Organization Name | JOHNS HOPKINS HOSPITAL |
| Address | 1800 Orleans St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 410-502-2958 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1861530867 |
| Organization Name | JOHNS HOPKINS UNIVERSITY |
| Address | 600 N Wolfe St, Blalock 1412, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 410-955-7609 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1871952101 |
| Organization Name | JOHNS HOPKINS HOSPITAL |
| Address | 600 N Wolfe St, Meyer 1-130, Baltimore, MD 21287 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 410-614-3235 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| NPI Number | 1982136008 |
| Organization Name | THE JOHNS HOPKINS HOSPITAL |
| Address | 1800 Orleans St, Baltimore, MD 21287 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 410-955-7911 |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Researchers at Osaka University clarified that the cell adhesion inhibition of periostin1 damages myocardinal cells, inducing compromised cardiac myocyte contractile force and myocytes death, leading to the onset of cardiac failure after AMI through the administration of periostin neutralizing antibodies they had developed on their own.
Surgery to reshape damaged hearts, which excludes scarred muscle tissue and restores the left ventricle's normal shape, may provide long-term benefits for certain patients with advanced heart failure
Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures, say neuroscientists at Georgetown University Medical Center.
Agile Therapeutics, Inc., a late-stage pharmaceutical company specializing in women's healthcare products, today announced that it completed a $45 million Series B Preferred Stock financing. The financing round was co-led by Investor Growth Capital and Care Capital, with strong participation from ProQuest Investments. Kaiser Permanente Ventures and Novitas Capital also joined the financing round. Investor Growth Capital, Care Capital, and Kaiser Permanente Ventures are new investors to Agile.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Labtronics Inc., an Ontario, Canada-based leader in providing procedures-based Electronic Laboratory Notebook solutions for laboratories performing routine analysis in multiple industries.
› Verified 4 days ago
University Of Maryland Medical Center Acute Care Hospital Location: 22 South Greene Street, Baltimore, Maryland 21201 Phone: (410) 328-8667 | |
Mercy Medical Center Inc Acute Care Hospital Location: 301 Saint Paul Place, Baltimore, Maryland 21202 Phone: (410) 332-9237 | |
Johns Hopkins Hospital, The Acute Care Hospital Location: 600 North Wolfe Street, Baltimore, Maryland 21287 Phone: (410) 955-9540 | |
Saint Agnes Hospital Acute Care Hospital Location: 900 Caton Avenue, Baltimore, Maryland 21229 Phone: (410) 368-2101 | |
Sinai Hospital Of Baltimore Acute Care Hospital Location: 2401 West Belvedere Avenue, Baltimore, Maryland 21215 Phone: (410) 601-5131 | |
Grace Medical Center, Inc Acute Care Hospital Location: 2000 W Baltimore Street, Baltimore, Maryland 21223 Phone: (410) 362-3000 |